AeroShot Caffeine Inhaler Scrutinized By FDA

Law360, New York (March 6, 2012, 3:13 PM EST) -- The U.S. Food and Drug Administration sent a warning letter Monday to the makers of the controversial AeroShot caffeine inhaler, saying the product is mislabeled and could be dangerous to users' health.

AeroShot, which is made by Breathable Foods Inc. and allows users to inhale 100 milligrams of caffeine and B vitamins, has been described by U.S. Sen. Charles Schumer, D-N.Y., as nothing more than a “club drug.” The FDA expressed concerns in Monday's letter about Breathable Foods' publicizing the use of AeroShot with alcohol and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.